{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:50:04Z","timestamp":1789019404923,"version":"build-2803163510"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.juro.2011.06.052","type":"journal-article","created":{"date-parts":[[2011,9,24]],"date-time":"2011-09-24T01:35:55Z","timestamp":1316828155000},"page":"2101-2106","source":"Crossref","is-referenced-by-count":44,"title":["Predicting Prostate Biopsy Result in Men With Prostate Specific Antigen 2.0 to 10.0 ng\/ml Using an Investigational Prostate Cancer Methylation Assay"],"prefix":"10.1097","volume":"186","author":[{"given":"Jonathan","family":"Baden","sequence":"first","affiliation":[{"name":"Ortho Clinical Diagnostics, a Johnson&Johnson Co., Raritan, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Adams","sequence":"additional","affiliation":[{"name":"Ortho Clinical Diagnostics, a Johnson&Johnson Co., Raritan, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Astacio","sequence":"additional","affiliation":[{"name":"Ortho Clinical Diagnostics, a Johnson&Johnson Co., Raritan, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Jones","sequence":"additional","affiliation":[{"name":"Ortho Clinical Diagnostics, a Johnson&Johnson Co., Raritan, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadwiga","family":"Markiewicz","sequence":"additional","affiliation":[{"name":"Ortho Clinical Diagnostics, a Johnson&Johnson Co., Raritan, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Painter","sequence":"additional","affiliation":[{"name":"Ortho Clinical Diagnostics, a Johnson&Johnson Co., Raritan, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Trust","sequence":"additional","affiliation":[{"name":"Ortho Clinical Diagnostics, a Johnson&Johnson Co., Raritan, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Wang","sequence":"additional","affiliation":[{"name":"Ortho Clinical Diagnostics, a Johnson&Johnson Co., Raritan, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Green","sequence":"additional","affiliation":[{"name":"Ortho Clinical Diagnostics, a Johnson&Johnson Co., Raritan, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2011.06.052_bib1","series-title":"Cancer Facts and Figures","first-page":"4","year":"2009"},{"key":"10.1016\/j.juro.2011.06.052_bib2","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0022-5347(17)40211-4","article-title":"Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen","volume":"143","author":"Cooner","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.06.052_bib3","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0090-4295(02)01950-7","article-title":"Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy","volume":"60","author":"Mian","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.juro.2011.06.052_bib4","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.277.18.1452","article-title":"Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng\/mL and benign prostate examination","volume":"277","author":"Catalona","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2011.06.052_bib5","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2011.06.052_bib6","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2011.06.052_bib7","series-title":"Prostate-Specific Antigen Best Practice Statement: 2009 Update","author":"Carroll","year":"2009"},{"key":"10.1016\/j.juro.2011.06.052_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0090-4295(96)00616-4","article-title":"In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples","volume":"48","author":"Piironen","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.juro.2011.06.052_bib9","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/S0022-5347(05)68093-7","article-title":"Significance and metabolism of complexed and noncomplexed prostate specific antigen forms and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy","volume":"162","author":"Lilja","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.06.052_bib10","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0022-5347(01)64711-6","article-title":"Biological variation of prostate specific antigen levels in serum: an evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patients","volume":"157","author":"Nixon","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.06.052_bib11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0090-4295(99)00611-1","article-title":"Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen","volume":"55","author":"Recker","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.juro.2011.06.052_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/pros.10180","article-title":"The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer","volume":"54","author":"Haese","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.juro.2011.06.052_bib13","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.juro.2007.11.038","article-title":"PCA3: a molecular urine assay for predicting prostate biopsy outcome","volume":"179","author":"Deras","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.06.052_bib14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.urology.2006.12.014","article-title":"PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy","volume":"69","author":"Marks","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.06.052_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1155\/2007\/356742","article-title":"Epigenetic markers for molecular detection of prostate cancer","volume":"23","author":"Costa","year":"2007","journal-title":"Dis Markers"},{"key":"10.1016\/j.juro.2011.06.052_bib16","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1158\/1078-0432.CCR-04-2446","article-title":"Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy","volume":"11","author":"Bastian","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2011.06.052_bib17","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1200\/JCO.2005.07.009","article-title":"Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects","volume":"23","author":"Hoque","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2011.06.052_bib18","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1373\/clinchem.2007.094912","article-title":"Development of a multiplexed urine assay for prostate cancer diagnosis","volume":"54","author":"Vener","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.juro.2011.06.052_bib19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.juro.2009.05.003","article-title":"A multicenter evaluation of an investigational prostate cancer methylation assay","volume":"182","author":"Baden","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.06.052_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnci\/djj131","article-title":"Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial","volume":"98","author":"Thompson","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2011.06.052_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.med.60.042307.110714","article-title":"Biomarkers for prostate cancer","volume":"60","author":"Makarov","year":"2009","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.juro.2011.06.052_bib22","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1097\/01.pas.0000168178.48535.0d","article-title":"High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: predictive value for cancer in current practice","volume":"29","author":"Schlesinger","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.juro.2011.06.052_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2288-8-75","article-title":"Statistical methods to correct for verification bias in diagnostic studies are inadequate when there are few false negatives: a simulation study","volume":"8","author":"Cronin","year":"2008","journal-title":"BMC Med Res Methodol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534711043278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534711043278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2011.06.052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T02:22:16Z","timestamp":1651198936000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2011.06.052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["10.1016\/j.juro.2011.06.052"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2011.06.052","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}